Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-21

Clinical Trial Update: Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating INL-001 for postsurgical analgesia in abdominoplasty, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INL-001

Snippet

Sponsor: Innocoll | Conditions: Pain, Postoperative, Abdominoplasty | Phase 3 | Status: COMPLETED